Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill, United States
Alkahest (Consultant/Advisory Board)Altimmune (Consultant/Advisory Board)Anji (Consultant/Advisory Board)asman Diabetes Center (Kuwait) (Consultant/Advisory Board)AstraZeneca (Consultant/Advisory Board)Bayer (Consultant/Advisory Board)Boehringer-Ingelheim (Consultant/Advisory Board)CeQur (Consultant/Advisory Board)Cirius Therapeutics Inc (Consultant/Advisory Board)Dexcom (Contracted Research)Eli Lilly (Consultant/Advisory Board)Fortress Biotech (Consultant/Advisory Board)GentiBio (Consultant/Advisory Board)Glycadia (Consultant/Advisory Board)Glyscend (Consultant/Advisory Board, Ownership Interest includes stock, stock options, patent or other intellectual property)Janssen (Consultant/Advisory Board)Mediflix (Consultant/Advisory Board)Medscape (Consultant/Advisory Board)Mellitus Health (Consultant/Advisory Board, Ownership Interest includes stock, stock options, patent or other intellectual property)NovaTarg (Contracted Research)Novo Nordisk (Contracted Research, Contracted consulting fees and travel support for contracted activities are paid to the University of North Carolina by Novo Nordisk)Pendulum Therapeutics (Consultant/Advisory Board, Ownership Interest includes stock, stock options, patent or other intellectual property)PhaseBio (Ownership Interest includes stock, stock options, patent or other intellectual property)Praetego (Consultant/Advisory Board, Ownership Interest includes stock, stock options, patent or other intellectual property)Sanofi (Contracted Research)Stability Health (Consultant/Advisory Board, Ownership Interest includes stock, stock options, patent or other intellectual property)Tolerion (Contracted Research)Valo (Consultant/Advisory Board)vTv Therapeutics (Contracted Research)Zealand Pharma (Consultant/Advisory Board)
Friday, August 26, 2022
2:00 PM – 2:15 PM CEST